Why the study?
Acute myocarditis often progresses to heart failure due to a lack of effective, etiology-targeted therapy.
Does simvastatin decrease MMPs activity, severity of inflammation, and contractile dysfunction in experimental rats with autoimmune myocarditis?
Does simvastatin decrease MMPs activity, severity of inflammation, and contractile dysfunction in experimental rats with autoimmune myocarditis?
Answers are grounded in this paper and cite their sources.
Simvastatin demonstrates cardioprotective effects in experimental autoimmune myocarditis by reducing MMP-9 activity, inflammation, and myofilament degradation.
BACKGROUND: Acute myocarditis often progresses to heart failure because there is no effective, etiology-targeted therapy of this disease. Simvastatin has been shown to be cardioprotective by decreasing matrix metalloproteinases' (MMPs) activity. The study was designed to determine whether simvastatin inhibits MMPs activity, decreases the severity of inflammation and contractile dysfunction of the heart in experimental autoimmune myocarditis (EAM). METHODS: Simvastatin (3 or 30 mg/kg/day) was given to experimental rats with EAM by gastric gavage for 21 days. Then transthoracic echocardiography was performed, MMPs activity and troponin I level were determined and tissue samples were assessed under a light and transmission electron microscope. RESULTS: Hearts treated with simvastatin did not show left ventricular enlargement. As a result of EAM, there was an enhanced activation of MMP-9, which was significantly reduced in the high-dose simvastatin group compared to the low-dose group. It was accompanied by prevention of myofilaments degradation and reduction of severity of inflammation. CONCLUSIONS: The cardioprotective effects of simvastatin in the acute phase of EAM are, at least in part, due to its ability to decrease MMP-9 activity and subsequent decline in myofilaments degradation and suppression of inflammation. These effects were achieved in doses equivalent to therapeutic doses in humans.
No takes yet. Share an insight, caveat, or question.
Skrzypiec‐Spring et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: